|Title:||Drug Polis : drug reimbursement pilot system, Kutaisi, Georgia : 1998 annual report|
|Authors:||World Health Organization. Regional Office for Europe|
|Publisher:||Copenhagen : WHO Regional Office for Europe|
|Abstract:||Concerned with the high levels of patients' payments for drugs, the Ministry of Health of Georgia considered a drug reimbursement system 6 however few funds might be available for it 6 a useful instrument to improve affordability of drugs and access to primary health care services. During 199661997, a new drug reimbursement concept (Drug Polis) was developed by the WHO Special Project for Newly Independent States (NIS) in collaboration with the Georgian health authorities, and tested in Kutaisi since October 1997. This new concept is a voluntary insurance scheme, for which a fixed participation fee (the price of a booklet) is levied regardless of income. Benefits are: 20% reduction in the fee for visiting a doctor, 10% discount on prescription drugs below an accumulated annual expenditure of 100 Lari, and 50% reimbursement for all additional prescription drugs per year. After a slow start, 12 000 booklets were sold by the end of 1998. The pilot scheme shows that a comprehensive drug reimbursement system appeals to two thirds of the population. This system, where benefits increase with growing drug expenditure, can also be financially feasible and well managed in the Georgian setting. It is probably less viable as a voluntary independent scheme and might be better incorporated in a health insurance scheme or primary health care package. The public appreciated the fixed premium or fee per insured person, independent of income. This is useful knowledge for other areas of health insurance. It is recommended that Drug Polis should be continued in a wider regional setting, while other pilot sites, preferably in combination with health insurance funds or an integrated primary health care project, will eventually improve the affordability of drugs in Georgia and inspire other NIS|
EUR/QCPH 08 32 03
20 p. + annexes.
Organization and Administration
Insurance, Health, Reimbursement
|metadata.dc.subject.other:||Pharmaceuticals and Biologicals|
|Gov't Doc #:||EUR/QCPH 08 32 03|
|Appears in Collections:||Technical documents|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.